BCRX FY 2015 Earnings — BioCryst Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

BCRXBioCryst Pharmaceuticals, Inc.

$2B

FY 2015 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$48M+254.6% YoY

Gross Profit

$46M96.1% margin

Operating Income

-$39M-81.7% margin

Net Income

-$43M-89.1% margin

EPS (Diluted)

$-0.59

Cash Flow

Operating Cash Flow

-$13M

Free Cash Flow

-$18M

Stock-Based Comp.

$10M

Balance Sheet

Total Assets

$125M

Total Liabilities

$77M

Stockholders' Equity

-$511M

Cash & Equivalents

$29M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$48M	$14M	+254.6%
Gross Profit	$46M	$13M	+243.8%
Operating Income	-$39M	-$46M	+13.8%
Net Income	-$43M	-$45M	+4.8%